Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 18Observational 2

Sponsor

Cancer Type

Thoracic 1Lymphoid 1

Conditions

Lymphoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 86Surgical Procedures, Operative 45Drug Therapy 33Radiotherapy 28Biopsy 26Neoadjuvant Therapy 24Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Magnetic Resonance Spectroscopy 17Immunotherapy 17Data Collection 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Liquid Biopsy 16pembrolizumab 15Observation 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 14Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Observational × penpulimab × Clear all
NCT05680038 2023-01-11

Penpulimab in Maintenance Therapy in Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Unknown
167 enrolled
Lymphoid

Lymphoma

NCT05319886 2022-05-20

AP

The First Affiliated Hospital of Xinxiang Medical College

Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡